| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CANLET.2013.12.024 |
| P698 | PubMed publication ID | 24374016 |
| P2093 | author name string | Hongyang Wang | |
| Jin Ding | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-23 | |
| P577 | publication date | 2013-12-25 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Multiple interactive factors in hepatocarcinogenesis | |
| P478 | volume | 346 |
| Q36029791 | A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. |
| Q44048380 | A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy |
| Q54209069 | A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. |
| Q39623624 | Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals. |
| Q64974192 | Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma. |
| Q37699397 | Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma |
| Q45885714 | Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts |
| Q41674640 | Cell-type specific functions of epidermal growth factor receptor are involved in development of hepatocellular carcinoma |
| Q89638449 | Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy |
| Q55279434 | Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study. |
| Q41705402 | Correlation between polymorphisms in DNA mismatch repair genes and the risk of primary hepatocellular carcinoma for the Han population in northern China |
| Q34467228 | Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy. |
| Q34007879 | Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A. |
| Q47553678 | Expression Analysis of Liver-Specific Circulating microRNAs in HCV-Induced Hepatocellular Carcinoma in Egyptian Patients |
| Q54230737 | Flavonoids Effects on Hepatocellular Carcinoma in Murine Models: A Systematic Review. |
| Q36346927 | Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway |
| Q37743491 | Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway |
| Q41646513 | HBx induces the proliferation of hepatocellular carcinoma cells via AP1 over-expressed as a result of ER stress. |
| Q90208536 | HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis |
| Q87725770 | Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression |
| Q38560320 | Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis? |
| Q40198594 | Interest of variations in microRNA-152 and -122 in a series of hepatocellular carcinomas related to hepatitis C virus infection. |
| Q35159686 | Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicin |
| Q48121743 | LAMC1 mRNA promotes malignancy of hepatocellular carcinoma cells by competing for MicroRNA-124 binding with CD151. |
| Q90427379 | MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition |
| Q40254590 | MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ. |
| Q58560500 | NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma |
| Q26746521 | Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation |
| Q36096614 | Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. |
| Q37629064 | Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy |
| Q92095926 | Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging |
| Q53085800 | Resource utilization and survival among Medicare patients with advanced liver disease. |
| Q34993924 | Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review) |
| Q41021406 | S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways |
| Q38881949 | Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway |
| Q34110436 | TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. |
| Q58696387 | Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis |
| Q51761242 | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. |
| Q38268953 | p53 in liver pathologies-taking the good with the bad. |
Search more.